Predicting tumour radiosensitivity to deliver precision radiotherapy
JM Price, A Prabhakaran, CML West - Nature Reviews Clinical …, 2023 - nature.com
Owing to advances in radiotherapy, the physical properties of radiation can be optimized to
enable individualized treatment; however, optimization is rarely based on biological …
enable individualized treatment; however, optimization is rarely based on biological …
New paradigms and future challenges in radiation oncology: an update of biological targets and technology
Radiation oncology exploits the biological interaction of radiation within tissue to promote
tumor death while minimizing damage to surrounding normal tissue. The clinical delivery of …
tumor death while minimizing damage to surrounding normal tissue. The clinical delivery of …
[HTML][HTML] COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma
M Yang, X Wu, J Hu, Y Wang, Y Wang, L Zhang… - Journal of …, 2022 - Elsevier
Background & Aims Copper (Cu) is an essential trace element whose serum levels have
been reported to act as an effective indicator of the efficacy of radiotherapy. However, little is …
been reported to act as an effective indicator of the efficacy of radiotherapy. However, little is …
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis
JG Scott, G Sedor, P Ellsworth, JA Scarborough… - The Lancet …, 2021 - thelancet.com
Background Despite advances in cancer genomics, radiotherapy is still prescribed on the
basis of an empirical one-size-fits-all paradigm. Previously, we proposed a novel algorithm …
basis of an empirical one-size-fits-all paradigm. Previously, we proposed a novel algorithm …
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Background Despite its common use in cancer treatment, radiotherapy has not yet entered
the era of precision medicine, and there have been no approaches to adjust dose based on …
the era of precision medicine, and there have been no approaches to adjust dose based on …
Validation of a radiosensitivity molecular signature in breast cancer
SA Eschrich, WJ Fulp, Y Pawitan, JA Foekens… - Clinical Cancer …, 2012 - AACR
Purpose: Previously, we developed a radiosensitivity molecular signature [radiosensitivity
index (RSI)] that was clinically validated in 3 independent datasets (rectal, esophageal, and …
index (RSI)] that was clinically validated in 3 independent datasets (rectal, esophageal, and …
Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy
KA Ahmed, JJ Caudell, G El-Haddad… - International Journal of …, 2016 - Elsevier
Purpose/Objectives Evidence from the management of oligometastases with stereotactic
body radiation therapy (SBRT) reveals differences in outcomes based on primary histology …
body radiation therapy (SBRT) reveals differences in outcomes based on primary histology …
Decision support systems for personalized and participative radiation oncology
A paradigm shift from current population based medicine to personalized and participative
medicine is underway. This transition is being supported by the development of clinical …
medicine is underway. This transition is being supported by the development of clinical …
[HTML][HTML] Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system
Radiotherapy is a primary therapeutic modality widely utilized with curative intent.
Traditionally tumor response was hypothesized to be due to high levels of cell death …
Traditionally tumor response was hypothesized to be due to high levels of cell death …
[HTML][HTML] The radiosensitivity index predicts for overall survival in glioblastoma
We have previously developed a multigene expression model of tumor radiosensitivity (RSI)
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …